Skip to main content

INTEGRACION DE APROXIMACIONES BASADAS EN REDES EN UNA PLATAFORMA BIOINFORMATICA PARA LA ASISTENCIA AL FENOTIPADO PROFUNDO Y GENOTIPADO EN DIAGNOSIS DE ENFERMEDADES RARAS

PID2022-140047OB-C22

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CoMentG: comprehensive retrieval of generic relationships between biomedical concepts from the scientific literature

  • Novoa, Jorge
  • López-Ibáñez, Javier
  • Chagoyen, Mónica
  • Ranea, Juan A. G.
  • Pazos, Florencio
The CoMentG resource contains millions of relationships between terms of biomedical interest obtained from the scientific literature. At the core of the system is a methodology for detecting significant co-mentions of concepts in the entire PubMed corpus. That method was applied to nine sets of terms covering the most important classes of biomedical concepts: diseases, symptoms/clinical signs, molecular functions, biological processes, cellular compartments, anatomic parts, cell types, bacteria and chemical compounds. We obtained more than 7 million relationships between more than 74 000 terms, and many types of relationships were not available in any other resource. As the terms were obtained from widely used resources and ontologies, the relationships are given using the standard identifiers provided by them and hence can be linked to other data. A web interface allows users to browse these associations, searching for relationships for a set of terms of interests provided as input, such as between a disease and their associated symptoms, underlying molecular processes or affected tissues. The results are presented in an interactive interface where the user can explore the reported relationships in different ways and follow links to other resources. Database URL: https://csbg.cnb.csic.es/CoMentG/., Spanish Ministry of Economy and Competitiveness with European Regional Development Fund (grant numbers PID2019-108096RB-C21 and PID2022-140047OB-C21 to J.A.G.R., PID2019-108096RB-C22 and PID2022-1400 47OB-C22 to F.P.); The Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (‘A way to make Europe’); The European Food Safety Authority (grant number GP/EFSA/ENCO/2020/02 to F.P.); and the European Union (grant number HORIZON-HLTH-2022-DISEASE-06, Project ID: 101080580 to J.A.G.R.). The conclusions, findings and opinions expressed in this scientific paper reflect only the view of the authors and not the official position of the Euro- pean Food Safety Authority. CIBERER is an initiative from the Institute of Health Carlos III., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Differential expression and co-expression reveal cell types relevant to genetic disorder phenotypes

  • Alías-Segura, Sergio
  • Pazos, Florencio
  • Chagoyen, Mónica
Knowledge of the specific cell types affected by genetic alterations in rare diseases is crucial for advancing diagnostics and treatments. Despite significant progress, the cell types involved in the majority of rare disease manifestations remain largely unknown. In this study, we integrated scRNA-seq data from non-diseased samples with known genetic disorder genes and phenotypic information to predict the specific cell types disrupted by pathogenic mutations for 482 disease phenotypes., This work was supported by the Spanish Ministry of Economy and Competitiveness with the European Regional Development Fund [grant numbers PID2019-108096RB-C22 and PID2022-140047OB-C22] to M.C. and F.P., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Deep Learning Approaches for the Prediction of Protein Functional Sites

  • Pitarch, Borja
  • Pazos, Florencio
Knowing which residues of a protein are important for its function is of paramount importance for understanding the molecular basis of this function and devising ways of modifying it for medical or biotechnological applications. Due to the difficulty in detecting these residues experimentally, prediction methods are essential to cope with the sequence deluge that is filling databases with uncharacterized protein sequences. Deep learning approaches are especially well suited for this task due to the large amounts of protein sequences for training them, the trivial codification of this sequence data to feed into these systems, and the intrinsic sequential nature of the data that makes them suitable for language models. As a consequence, deep learning-based approaches are being applied to the prediction of different types of functional sites and regions in proteins. This review aims to give an overview of the current landscape of methodologies so that interested users can have an idea of which kind of approaches are available for their proteins of interest. We also try to give an idea of how these systems work, as well as explain their limitations and high dependence on the training set so that users are aware of the quality of expected results., Spanish Ministry of Economy and Competitiveness with European Regional Development Fund (grant number PID2022-140047OB-C22 to F.P.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Better understanding the phenotypic effects of drugs through shared targets in genetic disease networks

  • Díaz-Santiago, Elena
  • Moya-García, Aurelio A.
  • Pérez-García, Jesús
  • Yahyaoui, Raquel
  • Orengo, Christine A.
  • Pazos, Florencio
  • Perkins, James R.
  • Ranea, Juan A. G.
[Introduction]: Most drugs fail during development and there is a clear and unmet need for approaches to better understand mechanistically how drugs exert both their intended and adverse effects. Gaining traction in this field is the use of disease data linking genes with pathological phenotypes and combining this with drugtarget interaction data., [Methods]: We introduce methodology to associate drugs with effects, both intended and adverse, using a tripartite network approach that combines drug-target and target-phenotype data, in which targets can be represented as proteins and protein domains., [Results]: We were able to detect associations for over 140,000 ChEMBL drugs and 3,800 phenotypes, represented as Human Phenotype Ontology (HPO) terms. The overlap of these results with the SIDER databases of known drug side effects was up to 10 times higher than random, depending on the target type, disease database and score threshold used. In terms of overlap with drug-phenotype pairs extracted from the literature, the performance of our methodology was up to 17.47 times greater than random. The top results include phenotype-drug associations that represent intended effects, particularly for cancers such as chronic myelogenous leukemia, which was linked with nilotinib. They also include adverse side effects, such as blurred vision being linked with tetracaine., [Discussion]: This work represents an important advance in our understanding of how drugs cause intended and adverse side effects through their action on disease causing genes and has potential applications for drug development and repositioning., This work was partially funded by The Spanish Ministry of Economy and Competitiveness with European Regional Development Fund (grant numbers PID2022-140047OB-C21 and PID 2022-140047OB-C22); the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”); IBIMA Plataforma BIONAND (PI RARE 24- 03); and the EURAS project. This publication is part of the project CPP2022-010108, funded by the Spanish Ministry of Science and Innovation (MCIU/AEI/10.13039/501100011033) and by the European Union under the “NextGenerationEU”/PRTR framework, as well as the project PI21/01042, funded by the Carlos III Health Institute (ISCIII) and co-funded by the European Union. The EURAS project receives funding from the European Union’s Horizon Europe Research and Innovation Programme under Grant Agreement No. 101080580. (HORIZON-HLTH-2022-DISEASE-06). Funded by the European Union., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A review on Gene Ontology evaluations

  • Pitarch, Borja
  • Chagoyen, Mónica
  • Ranea, Juan A G
  • Pazos, Florencio
The analysis of the large and heterogeneous datasets that characterize modern biology demands systems capable of representing biological knowledge in a formal, standardized manner. The most widely used structured vocabulary in molecular biology and biomedicine is the Gene Ontology (GO). Although employed in many different data analysis tasks, its main application is in the functional annotation of gene products and the subsequent functional enrichment analysis of large gene/protein datasets derived from omics experiments. This key position in modern biology means the GO is subject to continuous scrutiny and improvement, not only by its developers but by the community in general. GO's vocabulary, structure, and gene annotations have been evaluated from multiple points of view, revealing important insights into how we organize our biological knowledge, the associated problems, and strategies for overcoming them. These evaluations range from technical analyses of its ontological architecture to assessments of its effectiveness in supporting biological research. This process ensures that this essential resource is updated and adapted to the new challenges posed by modern biology. In this review, we summarize some key evaluations that the GO has undergone over time., Spanish Ministry of Economy and Competitiveness with European Regional Development Fund (grant numbers PID2022-140047OB-C21 to J.A.G.R. and PID2022-140047OB-C22 to F.P. and M.C.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Prediction of plant food allergens using protein embeddings

  • Méndez, Martín
  • Moreno, F. Javier
  • Pazos, Florencio
The predictor is open-source and freely available at GitHub: https://github.com/Martinmendezlopez/ALLERGEN-PREDICTOR-FROM-ProtTrans/, [Motivation] The current trend to incorporate new protein sources to the diet, mostly from plants, requires a safety assessment of these polypeptides when used as food. Part of that safety evaluation involves assessing the potential allergenicity of the proteins. Such assessment typically follows a hierarchy of in silico, in vitro and in vivo assays. The computational prediction of protein allergenicity is the first step in the process and several predictors are available for this task. Due to the complexity and heterogeneity of the allergy phenomenon, the large differences between allergens in their mechanisms of exposure and action, and the role of their inherent biological and physicochemical properties, predictors focused on particular organisms or subsets of allergens are in principle better than general predictors., [Results] In this work we present a predictor of protein allergenicity focused on plant food allergens. The predictor, trained on known plant food allergens and bona-fide plant non-allergens, represents proteins by their sequence embeddings, a deep-learning based representation known to capture important features of a protein’s function and properties. The predictor outperforms the typical prediction based on sequence similarity to other allergens, especially in terms of sensitivity. In spite of being trained on plant food allergens, the predictor also performs well when applied to allergens from other sources., [Availability and implementation] The system is available as an open-source package at Github: https://github.com/Martinmendezlopez/ALLERGEN-PREDICTOR-FROM-ProtTrans/, This work was partially supported by the Spanish Ministry of Economy and Competitiveness with European Regional Development Fund [grant number PID2022-140047OB-C22 to F.P.]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A text mining and ontology-based approach using phenotypes to obtain relevant literature for rare diseases

  • Pérez-García, Jesús
  • García-Criado, Federico
  • Pazos, Florencio
  • Chagoyen, Mónica
  • Rojano, Elena
  • Seoane, Pedro
  • Ranea, Juan A. G.
Diagnosing rare diseases remains a major challenge due to limited clinical knowledge and the frequent absence of diagnostic criteria. We present a digital framework that leverages large language models and biomedical text embeddings to bridge this gap. By mapping Human Phenotype Ontology terms to a shared vector space with millions of PubMed abstracts and full-text articles, our method enables phenotype-driven semantic search and ranks literature relevant to patient symptoms, even without explicit disease mentions. Validated on OMIM-derived benchmarks and applied to RASopathies, including NF1, Noonan, and Costello syndromes, our approach retrieved expected findings, supporting differential diagnosis and research. The framework is implemented in an open-source Python package, py-semtools, and it can be integrated into clinical decision support systems or adapted to other ontologies and corpora. This work demonstrates how AI-driven informatics can enhance rare disease diagnosis and exemplifies the role of digital tools in transforming precision medicine and healthcare delivery., This work is supported by funds from Spanish Ministry of Economy and Competitiveness [PID2019-108096RB-C21 and PID2022-140047OB-C21, PID2022-140047OB-C22]; the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”); and the European Union through the project EURAS (Horizon Europe HORIZON-HLTH-2022-DISEASE-06, Project ID: 101080580) to J.A.G.R. The EURAS project receives funding from the European Union’s Horizon Europe Research and Innovation Programme under grant agreement no. 101080580 (HORIZON-HLTH-2022-DISEASE-06). Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. Biomedicine research projects [PI-0075-2017 and PEER-0019-2020] are funded by Fundación Progreso y Salud. E.R. hold a research grant from the Instituto de Investigación Biomédica de Málaga (IBIMA-Plataforma BIONAND) [PI RARE 24-03]. J.P.G. is a predoctoral researcher from “ayudas para contratos predoctorales para la formación de doctores” (PRE2022/000510) supported by the Ministerio de Ciencia, Innovación y Universidades. F.G.C. is a predoctoral researcher from “ayudas para contratos predoctorales para la Formación del Profesorado Universitario” (FPU21/01449) supported by the Ministerio de Ciencia, Innovación y Universidades. The “CIBER de Enfermedades Raras” is an initiative from the ISCIII (Spain). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors thank the Supercomputing and Bioinnovation Center (SCBI) of the University of Málaga for their provision of computational resources and technical support (http://www.scbi.uma.es/site). We thank to Junta de Andalucía its support to PAIDI BIO-267 group., Peer reviewed